Oculis Holding AG Warrants

OCSAW
🚫 Oculis Holding AG Warrants does not pay dividends

Company News

Oculis Announces Presentation of Phase 2 ACUITY trial results with Privosegtor in Acute Optic Neuritis at ECTRIMS
GlobeNewswire Inc. • Oculis Holding Ag • September 22, 2025

Oculis presented positive Phase 2 trial results for Privosegtor, showing improved visual acuity and preservation of retinal ganglion cells in acute optic neuritis patients at the ECTRIMS 2025 Congress.

OCS

Related Companies

ClearShares OCIO ETF
ClearShares OCIO ETF
OCIO
Oculis Holding AG Ordinary shares
Oculis Holding AG Ordinary shares
OCS
Innovator Premium Income 10 Barrier ETF - October
Innovator Premium Income 10 Barrier ETF - October
OCTD
Oaktree Specialty Lending Corporation
Oaktree Specialty Lending Corporation
OCSL